Demodicidosis in a child with xantholeukaemia associated with type 1 neurofibromatosis.

Abstract

Although Demodex follicularum and Demodex brevis are common permanent ectoparasites of human pilosebaceous units, their incidence on children's skin is rare. We report a new case of demodicidosis in a 22-month-old girl undergoing chemotherapy for chronic myelomonocytic leukaemia associated with xanthoma and type 1 neurofibromatosis. The eruption cleared after oral and topical metronidazole therapy. Demodicidosis should be included in the differential diagnosis of facial eruption in immunosuppressed children.

• Authors: Mouna Benessahraoui, France Paratte, Emmanuel Plouvier, Philippe Humbert, François Aubin
• Journal: European journal of dermatology : EJD (Eur J Dermatol) 2003 May-Jun Vol. 13 Issue 3 Pg. 311-2 ISSN: 1167-1122 [Print] France
• PMID: 12804999 (Publication Type: Case Reports, Journal Article)

Chemical References

• Anti-Infective Agents
• Metronidazole

Topics

• Administration, Cutaneous
• Administration, Oral
• Animals
• Anti-Infective Agents (administration & dosage, therapeutic use)
• Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
• Diagnosis, Differential
• Facial Dermatoses (complications, diagnosis, drug therapy, pathology)
• Female
• Humans
• Immunocompromised Host
• Infant
• Leukemia, Myelomonocytic, Chronic (complications, drug therapy)
• Metronidazole (administration & dosage, therapeutic use)
• Mite Infestations (complications, diagnosis, drug therapy, pathology)
• Mites (classification)
• Neurofibromatosis 1 (complications, drug therapy)